Amethis acquired a ~30% stake in Globex Group, a Morocco-based provider of courier, freight, transit and storage services operating under brands including FedEx Express. Read more here and here. Read More
The infrastructure business of Goldman Sachs Asset Management agreed to invest in Goodpack, a Singapore-based provider of reusable metal storage containers. KKR took Goodpack private in 2014 for SGD1.4b (~USD1.1b). Read More… Read More
Old Mutual Alternative Investments (OMAI), through its Hybrid Equity fund, invested ZAR420m (~USD24m) to increase its stake in Mulilo, a South Africa-based renewable energy independent power producer. Hybrid Equity has been a shareholder in Mulilo since 2015. Read more… Read More
Studenac, a Croatia-based retail chain backed by Enterprise Investors, acquired Toni Marketi, a retailer operating 12 stores on the central Croatian Adriatic coast. Read More… Read More
Global Ventures’ Nclude fund led a USD3m seed round for OneOrder, an Egypt-based restaurant supply chain platform, with participation from A15 and Delivery Hero Ventures. Read More… Read More
Urban Innovation Fund led a USD4.4m seed round for Plenna, a Mexico-based women’s healthcare platform, with participation from Collaborative, 1984, Bridge Latam, Amador Holdings, Nido Ventures, Integra Groupe and Phoenix Club, and follow-on from 500 Global and Canary. Read More… Read More
European Bank for Reconstruction and Development (EBRD) committed EUR5m (~USD5m) to 500 Istanbul Fund II, 500 Global’s second Turkey- and CEE-focused fund. Read More… Read More
Ant Group led a USD14m Series A for Aigens, a Hong Kong-based provider of digital ordering and POS systems for restaurants, with participation from Velocity Ventures, Phillip Private Equity and Prizm Ventures. Read More… Read More
Highlight Capital led a ~CNY100m (~USD14m) pre-Series A for Silicon Innovation, a China-based chip developer, with participation from Greystar and follow-on from Glory Ventures and Rising Investments. Read More… Read More
Legend Capital led a ~CNY100m (~USD14m) pre-Series A for GS Biotech, a China-based developer of bio-based materials, with participation from Junsan Capital and Eastern Bell Capital. Read More… Read More
(default archive template)